Circulating Total Glutathione in Normal Tension Glaucoma Patients: Comparison with Normal Control Subjects
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Oxidative stress plays a critical role in the pathogenesis of glaucoma. Glutathione is a major antioxidant molecule present in intracellular or extracellular space. Herein, we aimed to examine circulating glutathione level in normal tension glaucoma (NTG), which comprises the largest proportion of glaucoma disease in the Korean population. Methods: Nineteen NTG patients (NTG group) and 30 age- and gender-matched normal control subjects (control group) were included. Antecubital venous puncture was performed between 8 and 10 o’clock in the morning to obtain a 4 mL venous blood sample. Total glutathione level was measured by the spectrophotometric method at 412 nm. Correlation of total glutathione level with mean deviation and pattern standard deviation from the Humphrey visual field test was analyzed in the NTG group. Results: Total glutathione level in circulating blood was 524.02 ± 231.09 nmol and 586.06 ± 156.08 nmol in the NTG group and the control group, respectively. The difference between these values was not statistically significant (p = 0.121, F = 2.212). Age had no significant effect on circulating total glutathione level in either the NTG group (p = 0.171, r = -0.328) or the control group (p = 0.380, r = -0.166). In the NTG group, circulating total glutathione level had no significant relationship with mean deviation (p = 0.226, F = 1.636) and pattern standard deviation (p = 0.200, F = 1.766) after correcting for age and gender. Conclusions: In NTG patients, circulating total glutathione levels were not different compared to those of normal subjects.
Abstract
Purpose: Oxidative stress plays a critical role in the pathogenesis of glaucoma. Glutathione is a major antioxidant molecule present in intracellular or extracellular space. Herein, we aimed to examine circulating glutathione level in normal tension glaucoma (NTG), which comprises the largest proportion of glaucoma disease in the Korean population. Methods: Nineteen NTG patients (NTG group) and 30 age- and gender-matched normal control subjects (control group) were included. Antecubital venous puncture was performed between 8 and 10 o’clock in the morning to obtain a 4 mL venous blood sample. Total glutathione level was measured by the spectrophotometric method at 412 nm. Correlation of total glutathione level with mean deviation and pattern standard deviation from the Humphrey visual field test was analyzed in the NTG group. Results: Total glutathione level in circulating blood was 524.02 ± 231.09 nmol and 586.06 ± 156.08 nmol in the NTG group and the control group, respectively. The difference between these values was not statistically significant (p = 0.121, F = 2.212). Age had no significant effect on circulating total glutathione level in either the NTG group (p = 0.171, r = -0.328) or the control group (p = 0.380, r = -0.166). In the NTG group, circulating total glutathione level had no significant relationship with mean deviation (p = 0.226, F = 1.636) and pattern standard deviation (p = 0.200, F = 1.766) after correcting for age and gender. Conclusions: In NTG patients, circulating total glutathione levels were not different compared to those of normal subjects.
참고문헌 (60)
- Quigley HA, "The number of people withglaucoma worldwide in 2010 and 2020", Br J Ophthalmol, 90, pp.262~267 (2006)
- Liesegang TJ, "Glaucoma: changing concepts and futuredirections", Mayo Clin Proc, 71, pp.689~694 (1996)
- Quigley HA, "The histology of human glaucomacupping and optic nerve damage: clinicopathologiccorrelation in 21 eyes", Ophthalmology, 86, pp.1803~1830 (1979)
- Krakau CE, "Intraocular pressure elevation-cause or effectin chronic glaucoma?", Ophthalmologica, 182, pp.141~147 (1981)
- Shen F, "Glutamate-induced glutaminesynthetase expression in retinal Muller cells aftershort-term ocular hypertension in the rat", Invest OphthalmolVis Sci, 45, pp.3107~3112 (2004)
- Chung HS, "Vascular aspectsin the pathophysiology of glaucomatous optic neuropathy", Surv Ophthalmol, 43(1), pp.43~50 (1999)
- Flammer J, "The impact of ocularblood flow in glaucoma", Prog Retin Eye Res, 21, pp.359~393 (2002)
- Butt Z, "Color Doppler imagingin untreated high- and normal-pressure open-angleglaucoma", Invest Ophthalmol Vis Sci, 38, pp.690~696 (1997)
- Findl O, "Assessment of opticdisk blood flow in patients with open-angle glaucoma", AmJ Ophthalmol, 130, pp.589~596 (2000)
- Flammer J, "Vascular dysregulation:a principal risk factor for glaucomatous damage?", J Glaucoma, 8, pp.212~219 (1999)
- Flammer J, "What is the present pathogeneticconcept of glaucomatous optic neuropathy?", SurvOphthalmol, 52(2), pp.162~173 (2007)
- Moreno MC, "Retinal oxidativestress induced by high intraocular pressure", Free RadicBiol Med, 37, pp.803~812 (2004)
- Galassi F, "Nitric oxide proxies andocular perfusion pressure in primary open angle glaucoma", Br J Ophthalmol, 88, pp.757~760 (2004)
- Alvarado J, "Age-relatedchanges in trabecular meshwork cellularity", Invest OphthalmolVis Sci, 21, pp.714~727 (1981)
- Alvarado J, "Trabecular meshwork cellularityin primary open-angle glaucoma and nonglaucomatousnormals", Ophthalmology, 91, pp.564~579 (1984)
- Zhou L, "Oxidative stress affects cytoskeletalstructure and cell-matrix interactions in cells froman ocular tissue: the trabecular meshwork", J Cell Physiol, 180, pp.182~189 (1999)
- Sacca SC, "Oxidative DNAdamage in the human trabecular meshwork: clinical correlationin patients with primary open-angle glaucoma", ArchOphthalmol, 123, pp.458~463 (2005)
- Wang N, "Activationof a tissue-specific stress response in the aqueous outflowpathway of the eye defines the glaucoma disease phenotype", Nat Med, 7, pp.304~309 (2001)
- Sacca SC, "Glaucomatousoutflow pathway and oxidative stress", Exp Eye Res, 84, pp.389~399 (2007)
- Izzotti A, "The role of oxidative stressin glaucoma", Mutat Res, 612, pp.105~114 (2006)
- Ko ML, "The combined effectof brain-derived neurotrophic factor and a free radicalscavenger in experimental glaucoma", Invest OphthalmolVis Sci, 41, pp.2967~2971 (2000)
- Tanito M, "Change of redoxstatus and modulation by thiol replenishment in retinalphotooxidative damage", Invest Ophthalmol Vis Sci, 43, pp.2392~2400 (2002)
- Wangsa-Wirawan ND, "Retinal oxygen:fundamental and clinical aspects", Arch Ophthalmol, 121, pp.547~557 (2003)
- Siskova A, "The effects of hyperoxia, hypoxia,and ischemia", reperfusion on the activity of cytochromeoxidase from the rat retina, 2001, pp.50, 267~273
- Hirose F, "In vivo evaluation ofretinal injury after transient ischemia in hypertensive rats", Hypertension, 43, pp.1098~1102 (2004)
- Hanashima C, "Reduced viability of vascularendothelial cells by high concentration of ascorbic acid invitreous humor", Cell Biol Int, 23, pp.287~298 (1999)
- Brubaker RF, "Ascorbic acid content of human corneal epithelium", InvestOphthalmol Vis Sci, 41, pp.1681~1683 (2000)
- Dreyer R, "Lacrimal gland uptake and metabolismof ascorbic acid", Proc Soc Exp Biol Med, 202, pp.212~216 (1993)
- Ringvold A, "Distribution ofascorbate in the anterior bovine eye", Invest Ophthalmol VisSci, 41, pp.20~23 (2000)
- Giblin FJ, "A directcorrelation between the levels of ascorbic acid and H2O2 inaqueous humor", Exp Eye Res, 38, pp.87~93 (1984)
- Richer SP, "Water soluble antioxidants in mammalianaqueous humor: interaction with UV B and hydrogenperoxide", Vision Res, 38, pp.2881~2888 (1998)
- Kahn MG, "Glutathione in calf trabecularmeshwork and its relation to aqueous humor outflowfacility", Invest Ophthalmol Vis Sci, 24, pp.1286~1287 (1983)
- Truscott RJ, "Age-related nuclear cataract-oxidation is thekey", Exp Eye Res, 80, pp.709~725 (2005)
- Yildirim O, "Changes in antioxidantenzyme activity and malondialdehyde level in patientswith age-related macular degeneration", Ophthalmologica, 218, pp.202~206 (2004)
- Chen JZ, "A new clue to glaucoma pathogenesis", Am J Med, 114, pp.697~698 (2003)
- Dringen R, "Glutathione metabolism and oxidative stress inneurodegeneration", Eur J Biochem, 267, pp.4903~ (2000)
- Hall AG, "Review: the role of glutathione in the regulationof apoptosis", Eur J Clin Invest, 29, pp.238~245 (1999)
- Riley MV, "Physiologic neutralization mechanisms and theresponse of the corneal endothelium to hydrogen peroxide", CLAO J, 16(1 Suppl), pp.16~21 (1990)
- Costarides AP, "Roles of catalase andthe glutathione redox cycle in the regulation of anteriorchamberhydrogen peroxide", Ophthalmic Res, 23, pp.284~294 (1991)
- Ferreira SM, "Oxidative stressmarkers in aqueous humor of glaucoma patients", Am JOphthalmol, 137, pp.62~69 (2004)
- Yang J, "Serum autoantibody againstglutathione S-transferase in patients with glaucoma", InvestOphthalmol Vis Sci, 42, pp.1273~1276 (2001)
- Unal M, "Glutathione Stransferase M1 and T1 genetic polymorphisms are relatedto the risk of primary open-angle glaucoma: a study in aTurkish population", Br J Ophthalmol, 91, pp.527~530 (2007)
- Gherghel D, "Systemic reductionin glutathione levels occurs in patients with primaryopen-angle glaucoma", Invest Ophthalmol Vis Sci, 46, pp.877~883 (2005)
- Roh YJ, "Glutathione depletioninduces differential apoptosis in cells of mouse retina, invivo", Neurosci Lett, 417, pp.266~270 (2007)
- Park JW, "Differential expressionof heat shock protein mRNAs under in vivo glutathionedepletion in the mouse retina", Neurosci Lett, 413, pp.260~264 (2007)
- Choe YJ, "The prevalence of glaucoma in Koreancareermen", J Korean Ophthalmol Soc, 34, pp.153~158 (1993)
- Iwase A, "The prevalence of primaryopen-angle glaucoma in Japanese: the Tajimi Study", Ophthalmology, 111, pp.1641~1648 (2004)
- Kim CS, "Prevalence of primaryopen-angle glaucoma in central South Korea the Namilstudy", Ophthalmology, 118, pp.1024~1030 (2011)
- "Comparison of glaucomatous progression between untreatedpatients with normal-tension glaucoma and patientswith therapeutically reduced intraocular pressures: CollaborativeNormal-Tension Glaucoma Study Group", Am JOphthalmol, 126, pp.487~497 (1998)
- "The effectiveness of intraocular pressure reduction inthe treatment of normal-tension glaucoma: CollaborativeNormal-Tension Glaucoma Study Group", Am J Ophthalmol, 126, pp.498~505 (1998)
- Allingham RR, "Neuroprotection and other investigational drugs, In Shields’ textbook ofglaucoma", pp.512~515 (2005), Lippincott Williams & Wilkins
- Brubaker RF, "Delayed functional loss in glaucoma: LIIEdward Jackson Memorial Lecture", Am J Ophthalmol, 121, pp.473~483 (1996)
- Akerboom TP, "Assay of glutathione, glutathionedisulfide, and glutathione mixed disulfides in biologicalsamples", Methods Enzymol, 77, pp.373~382 (1981)
- Nguyen KP, "Glutathionereductase of calf trabecular meshwork", Invest OphthalmolVis Sci, 26, pp.887~890 (1985)
- Levin LA, "Effect of lipid peroxidationinhibition on retinal ganglion cell death", Invest OphthalmolVis Sci, 37, pp.2744~2749 (1996)
- Izzotti A, "Oxidativedeoxyribonucleic acid damage in the eyes of glaucoma patients", Am J Med, 114, pp.638~646 (2003)
- Schutte M, "Redistribution of glutathione in theischemic rat retina", Neurosci Lett, 246, pp.53~56 (1998)
- Carter-Dawson L, "Glutathionecontent is altered in Muller cells of monkey eyes withexperimental glaucoma", Neurosci Lett, 364, pp.7~10 (2004)
- Kim SH, "The change of bloodreduced glutathione according to postmenopausal HRT:GSH as a marker of antioxidant effect of the sex steroids", JKorean Soc Menopause, 3, pp.116~125 (1997)
- 박동균, "헬리코박터 파이로리에 감염된 위점막의 Glutathione 농도에 관한 연구", 대한소화기학회지, 42(4) (2003), 대한소화기학회
